ALK-abello (4AJ0) Price & Analysis

2 Followers

4AJ0 Stock Chart & Stats

€30.44

€0.44(1.47%)

At close: Jul 24 4:00 PM EDT

€30.44

€0.44(1.47%)

Day’s Range― - ―

52-Week Range€23.68 - €36.28

Previous CloseN/A

Volume0.00

Average Volume (3M)10.00

Market Cap

€6.61B

Enterprise Value€43.67K

Total Cash (Recent Filing)€316.00M

Total Debt (Recent Filing)€990.00M

Price to Earnings (P/E)38.5

Beta0.24

Next Earnings

Aug 20, 2026

EPS Estimate

0.2

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)4.28

Shares Outstanding202,567,200

10 Day Avg. Volume17

30 Day Avg. Volume10

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€40.80

Price Target Upside34.04% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ALK-abello News

ALK-Abello initiated with a Buy at Berenberg

Berenberg initiated coverage of ALK-Abello (AKBLF) with a Buy rating and DKK 305 price target The firm says...

2M ago

ALK-Abelló Lifts Outlook After Strong Q1 Call

ALK-abello A/S Class B (($DK:ALK.B)) has held its Q1 earnings call. Read on for the main highlights of...

3M ago

ALK-Abelló Earnings Call Signals Profitable Growth

ALK-abello A/S Class B (($DK:ALK.B)) has held its Q4 earnings call. Read on for the main highlights of...

5M ago

ALK-Abelló Reports Strong Q3 Growth and Upgrades Outlook

ALK-abello A/S Class B ( ($AKBLF) ) has released its Q3 earnings. Here is a breakdown of the...

9M ago

ALK-abello A/S Earnings Call Highlights Growth and Challenges

ALK-abello A/S Class B (($DK:ALK.B)) has held its Q3 earnings call. Read on for the main highlights of...

9M ago

Is AKBLF a Buy, Before Earnings?

ALK-abello A/S Class B (AKBLF) is scheduled to report 3rd quarter earnings on 11/13/2025. Regarding Q3 estimates, Wall...

9M ago

ALK-abello Earnings Call: Strong Growth Amid Challenges

ALK-abello A/S Class B (($DK:ALK.B)) has held its Q2 earnings call. Read on for the main highlights of...

11M ago

ALK-Abelló A/S Reports Strong Q2 2025 Earnings Growth

ALK-abello A/S Class B ( ($AKBLF) ) has released its Q2 earnings. Here is a breakdown of the...

12M ago

ALK-abello A/S Class B (AKBLF) Q2 Earnings Cheat Sheet

ALK-abello A/S Class B (AKBLF) is scheduled to report 2nd quarter earnings on 08/21/2025. Regarding Q2 estimates, Wall...

12M ago

ALK-abello A/S Earnings Call Highlights Robust Growth

ALK-abello A/S Class B (($DK:ALK.B)) has held its Q1 earnings call. Read on for the main highlights of...

1y ago

ALK-Abelló A/S Reports Strong Q1 2025 Growth

ALK-abello A/S Class B ( ($AKBLF) ) has released its Q1 earnings. Here is a breakdown of the...

1y ago

ARS Pharmaceuticals Air Lease ALK-Abello

ARS Pharmaceuticals (SPRY) announced that the company has entered into an agreement with ALK-Abello A/S (AKBLF) to co-promote...

1y ago

SPRY

ALK-Abello says FDA approves label expansion for Odactra

ALK announced that the U.S. FDA expanded its indication of Odactra for the treatment of house dust mite-induced...

1y ago

ALK-Abello upgraded to Buy from Hold at Jefferies

Jefferies upgraded ALK-Abello (AKBLF) to Buy from Hold with a price target of DKK 185, up from DKK...

2y ago

4AJ0 FAQ

What was ALK-abello A/S Class B’s price range in the past 12 months?

ALK-abello A/S Class B lowest stock price was €23.68 and its highest was €36.28 in the past 12 months.

What is ALK-abello A/S Class B’s market cap?

ALK-abello A/S Class B’s market cap is €6.61B.

When is ALK-abello A/S Class B’s upcoming earnings report date?

ALK-abello A/S Class B’s upcoming earnings report date is Aug 20, 2026 which is in 16 days.

How were ALK-abello A/S Class B’s earnings last quarter?

ALK-abello A/S Class B released its earnings results on May 04, 2026. The company reported €0.268 earnings per share for the quarter, beating the consensus estimate of €0.227 by €0.04.

Is ALK-abello A/S Class B overvalued?

According to Wall Street analysts ALK-abello A/S Class B’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ALK-abello A/S Class B pay dividends?

ALK-abello A/S Class B does not currently pay dividends.

What is ALK-abello A/S Class B’s EPS estimate?

ALK-abello A/S Class B’s EPS estimate is 0.2.

How many shares outstanding does ALK-abello A/S Class B have?

ALK-abello A/S Class B has 202,567,200 shares outstanding.

What happened to ALK-abello A/S Class B’s price movement after its last earnings report?

ALK-abello A/S Class B reported an EPS of €0.268 in its last earnings report, beating expectations of €0.227. Following the earnings report the stock price went up 7.276%.

Which hedge fund is a major shareholder of ALK-abello A/S Class B?

Currently, no hedge funds are holding shares in DE:4AJ0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ALK-abello A/S Class B

ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.

ALK-abello (4AJ0) Earnings & Revenues

Historic Earnings Reports

4AJ0 Company Deck

4AJ0 Earnings Call

Q1 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call was predominantly positive: the company delivered strong Q1 financial results (18% revenue growth, 22% EBIT growth, 32% EBIT margin), achieved a major tablet sales milestone (over DKK 1 billion in a quarter), upgraded full-year guidance, reported robust regional and anaphylaxis product growth, and announced a successful Phase II peanut trial and key neffy regulatory approvals. Notable challenges include higher capacity costs (+23%), international shipment phasing (notably Japan) causing a -17% tablet decline in some markets, partner-related lower-margin revenue expected to rise, neffy market-access hurdles (UK local formularies, U.S. access), potential German pricing/rebate risk, and planned increased R&D/commercial spending for upcoming phases. Overall, the positives materially outweigh the negatives given upgraded guidance, cash generation, and strategic clinical progress.View all DE:4AJ0 earnings summaries

4AJ0 Stock 12 Month Forecast

Average Price Target

€40.80

▲(34.04% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"€24","41":"€41","28.25":"€28.3","32.5":"€32.5","36.75":"€36.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40.803205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€40.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40.803205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€40.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40.803205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€40.80</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,28.25,32.5,36.75,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.66,33.28640038461538,33.91280076923076,34.53920115384615,35.16560153846154,35.79200192307692,36.418402307692304,37.04480269230769,37.67120307692308,38.29760346153846,38.924003846153845,39.55040423076923,40.17680461538461,{"y":40.803205,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.66,33.28640038461538,33.91280076923076,34.53920115384615,35.16560153846154,35.79200192307692,36.418402307692304,37.04480269230769,37.67120307692308,38.29760346153846,38.924003846153845,39.55040423076923,40.17680461538461,{"y":40.803205,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.66,33.28640038461538,33.91280076923076,34.53920115384615,35.16560153846154,35.79200192307692,36.418402307692304,37.04480269230769,37.67120307692308,38.29760346153846,38.924003846153845,39.55040423076923,40.17680461538461,{"y":40.803205,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.202,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.222,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.531,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.623,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.881,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":31.234,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":30.341,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.159,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.635,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.34,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":32.16,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.52,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.66,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >